TEW-7197 With Paclitaxel for the Treatment of Metastatic Gastric Cancer
Status:
Active, not recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This is an open-label, single arm study evaluating the safety and tolerability of TEW-7197 in
combination with paclitaxel in metastatic gastric cancer patients.